268 related articles for article (PubMed ID: 8079395)
1. Leprosy reactions. New knowledge.
Naafs B
Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
[No Abstract] [Full Text] [Related]
2. Current views on reactions in leprosy.
Naafs B
Indian J Lepr; 2000; 72(1):97-122. PubMed ID: 10935190
[No Abstract] [Full Text] [Related]
3. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
Dawlah ZM; Cabrera A; Ahern K; Levis WR
Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
[No Abstract] [Full Text] [Related]
4. Localized and persistent erythema nodosum leprosum - a rare variant?
Prabhu S; Rao R; Sripathi H; Rao L; Singh R
Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
[TBL] [Abstract][Full Text] [Related]
5. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Naafs B
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
[No Abstract] [Full Text] [Related]
6. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
Kar HK; Raina A; Sharma PK; Bhardwaj M
Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
[TBL] [Abstract][Full Text] [Related]
7. Localized borderline lepromatous leprosy.
Arunthathi S; Samuel J; Ebenezer GJ; Jacob M
Indian J Lepr; 1995; 67(2):177-81. PubMed ID: 8537706
[No Abstract] [Full Text] [Related]
8. The role of mycophenolate mofetil in the treatment of leprosy reactions.
Burdick AE; Ramirez CC
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):127-8. PubMed ID: 16830656
[No Abstract] [Full Text] [Related]
9. Erythema nodosum leprosum in subgroups of lepromatous leprosy.
Bhargava P; Kuldeep CM; Mathur NK
Lepr Rev; 1997 Dec; 68(4):373-5. PubMed ID: 9503874
[No Abstract] [Full Text] [Related]
10. Experimental borderline lepromatous leprosy with intraneural erythema nodosum leprosum in a mangabey monkey (Cercocebus atys).
Baskin GB; Gormus BJ; Xu K; Martin LN; Wolf RH; Cantrell C; Pezeshkpour GH; Walsh GP; Malaty R; Meyers WM
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):618-23. PubMed ID: 1802944
[TBL] [Abstract][Full Text] [Related]
11. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
12. Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction.
Gunawan H; Yogya Y; Hafinah R; Marsella R; Ermawaty D; Suwarsa O
Int J Mycobacteriol; 2018; 7(1):97-100. PubMed ID: 29516895
[TBL] [Abstract][Full Text] [Related]
13. Chemoimmunotherapy: its relevance in contemporary context.
Sehgal VN; Jain S
Int J Dermatol; 1994 Oct; 33(10):753-4. PubMed ID: 8002151
[No Abstract] [Full Text] [Related]
14. Lepromatous leprosy treated with combined chemotherapy and immunotherapy (injection BCG): three case reports.
Lakshmi C; Srinivas CR
Int J Dermatol; 2014 Jan; 53(1):61-5. PubMed ID: 23675902
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
[TBL] [Abstract][Full Text] [Related]
16. Diffuse alopecia of the scalp in borderline-lepromatous leprosy in an Indian patient.
Abraham S; Ebenezer GJ; Jesudasan K
Lepr Rev; 1997 Dec; 68(4):336-40. PubMed ID: 9503871
[TBL] [Abstract][Full Text] [Related]
17. [Bullous erythema nodosum leprosum. A case report in French Guiana].
Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
[TBL] [Abstract][Full Text] [Related]
18. Reactions in borderline leprosy.
Ramu G; Desikan KV
Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
[TBL] [Abstract][Full Text] [Related]
19. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
[TBL] [Abstract][Full Text] [Related]
20. Inside the skin: the local immune and inflammatory milieu in leprosy.
Scollard DM
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
